全文获取类型
收费全文 | 1263901篇 |
免费 | 94816篇 |
国内免费 | 1578篇 |
专业分类
耳鼻咽喉 | 16313篇 |
儿科学 | 41009篇 |
妇产科学 | 34948篇 |
基础医学 | 189398篇 |
口腔科学 | 34731篇 |
临床医学 | 117757篇 |
内科学 | 247798篇 |
皮肤病学 | 27281篇 |
神经病学 | 101847篇 |
特种医学 | 46762篇 |
外国民族医学 | 265篇 |
外科学 | 178612篇 |
综合类 | 25751篇 |
现状与发展 | 3篇 |
一般理论 | 568篇 |
预防医学 | 104650篇 |
眼科学 | 28061篇 |
药学 | 92556篇 |
7篇 | |
中国医学 | 2022篇 |
肿瘤学 | 69956篇 |
出版年
2018年 | 13530篇 |
2017年 | 10390篇 |
2016年 | 11325篇 |
2015年 | 13083篇 |
2014年 | 18000篇 |
2013年 | 27483篇 |
2012年 | 37577篇 |
2011年 | 39969篇 |
2010年 | 23054篇 |
2009年 | 22253篇 |
2008年 | 37754篇 |
2007年 | 40387篇 |
2006年 | 39971篇 |
2005年 | 39103篇 |
2004年 | 37556篇 |
2003年 | 35971篇 |
2002年 | 34876篇 |
2001年 | 56032篇 |
2000年 | 57045篇 |
1999年 | 48096篇 |
1998年 | 13396篇 |
1997年 | 12225篇 |
1996年 | 12643篇 |
1995年 | 11914篇 |
1994年 | 11107篇 |
1993年 | 10399篇 |
1992年 | 38198篇 |
1991年 | 37671篇 |
1990年 | 36445篇 |
1989年 | 35258篇 |
1988年 | 32691篇 |
1987年 | 32027篇 |
1986年 | 30524篇 |
1985年 | 28786篇 |
1984年 | 21941篇 |
1983年 | 19192篇 |
1982年 | 11364篇 |
1981年 | 10321篇 |
1979年 | 20944篇 |
1978年 | 15393篇 |
1977年 | 12790篇 |
1976年 | 11845篇 |
1975年 | 12810篇 |
1974年 | 15588篇 |
1973年 | 15362篇 |
1972年 | 14512篇 |
1971年 | 13552篇 |
1970年 | 12786篇 |
1969年 | 12065篇 |
1968年 | 11229篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
993.
994.
995.
Immunization with amyloid-β (Aβ) peptide reduces amyloid load in animal studies and in humans; however clinical trials resulted in the development of a pro-inflammatory cellular response to Aβ. Apoptosis has been employed to stimulate humoral and Th2-biased cellular immune responses. Thus, we sought to investigate whether immunization using a DNA vaccine encoding Aβ in conjunction with an attenuated caspase generates therapeutically effective antibodies. Plasmids encoding Aβ and an attenuated caspase were less effective in reducing amyloid pathology than those encoding Aβ alone. Moreover, use of Aβ with an Arctic mutation (E22G) as an immunogen was less effective than wild-type Aβ in terms of improvements in pathology. Low levels of IgG and IgM were generated in response to immunization with a plasmid encoding wild-type Aβ. These antibodies decreased plaque load by as much as 36 ± 8% and insoluble Aβ42 levels by 56 ± 3%. Clearance of Aβ was most effective when antibodies were directed against N-terminal epitopes of Aβ. Moreover, immunization reduced CAA by as much as 69 ± 12% in TgCRND8 mice. Finally, high-molecular-weight oligomers and Aβ trimers were significantly reduced with immunization. Thus, immunization with a plasmid encoding Aβ alone drives an attenuated immune response that is sufficient to clear amyloid pathology in a mouse model of Alzheimer's disease. 相似文献
996.
997.
998.
999.
1000.
Saskia L.M.A. Beeres MD Katja Zeppenfeld MD Jeroen J. Bax MD Petra Dibbets-Schneider Marcel P.M. Stokkel MD Willem E. Fibbe MD Ernst E. van der Wall MD Douwe E. Atsma MD Martin J. Schalij MD 《Heart rhythm》2007,4(3):257-265
BACKGROUND: Bone marrow cell injection has been introduced to treat patients with ischemic heart disease. However, focal application of bone marrow cells may generate an arrhythmogenic substrate. OBJECTIVES: To assess the electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia. METHODS: Bone marrow was aspirated in 20 patients (65+/-11 years, 19 male) with drug-refractory angina and myocardial ischemia. Electroanatomical mapping (NOGA, Biosense-Webster, Waterloo, Belgium) was performed during mononuclear cell isolation. Areas for cell injection were selected based on the localization of ischemia on SPECT. These areas were mapped in detail to evaluate local bipolar electrogram duration, amplitude and fragmentation. Mononuclear cells were injected in the ischemic area with the NOGA system. SPECT and electroanatomical mapping were repeated at 3 months. Holter monitoring was repeated at 3 and 6 months. RESULTS: SPECT revealed a decrease in the number of segments with ischemia (3.5+/-2.5 vs. 1.1+/-1.0 at 3 months; P<0.01) and an increased left ventricular ejection fraction (44+/-13% vs. 49+/-17% at 3 months; P=0.02). The number of ventricular premature beats remained unchanged (10+/-24x10(2)/24h vs. 8+/-23x10(2)/24h at 3 months (P=NS) and 12+/-30x10(2)/24h at 6 months (P=NS)). At 3 months follow-up, bone marrow cell injection did not prolong electrogram duration (15.9+/-4.6 ms vs. 15.6+/-4.0 ms; P=NS), decrease electrogram amplitude (3.8+/-1.5 mV vs. 3.8+/-1.5 mV; P=NS), or increase fragmentation (2.0+/-0.5 vs. 1.9+/-0.4; P=NS). CONCLUSION: Intramyocardial bone marrow cell injection does not increase the incidence of ventricular arrhythmias and does not alter the electrophysiological properties of the injected myocardium. 相似文献